Eli Lilly, manufacturer of the competing GLP-1 medication tirzepatide (Mounjaro, Zepbound), has filed lawsuits against some compounding pharmacies
The most common side effects are nausea and mild GI-related symptoms, particularly when first starting the program
Comparative effectiveness and safety of sodium-glucose cotransporter 2 inhibitors versus glucagon-like peptide 1 receptor agonists in older adults
The FDA is evaluating use of a higher weekly 2.4 mg dose for chronic weight management
Careful patient selection and monitoring can help minimize these adverse cutaneous events
This mix has become the gold standard in growth hormone secretagogue research due to its potent effects on GH rise, clean pharmacology with minimal side effects, maintenance of natural pulsatile GH patterns, and full benefits for body makeup, healing, and anti-aging